Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1994-06-08
1997-12-09
Eisenschenk, Frank C.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241471, 42419611, 4241781, 4352351, 5303883, 5303873, A61K 39395, C07K 1608, C07K 1646
Patent
active
056957572
ABSTRACT:
Pharmaceutical compositions that comprise a pharmaceutically acceptable carrier or diluent and a antibodies that each comprise at least a portion of the variable region from MAb 1112-1 are disclosed. Methods of treating individuals suspected of exposure to rabies are disclosed.
REFERENCES:
Morrison, Hosp. Pract., 1989, 24:65-69, The Merck Manual of Diagnosis & Therapy, 16th Ed., 1992, pp. 205-208.
Harris and Emery, "Therapeutic Antibodies--the coming of age", TIB TECH 11: 42-44 (1993).
Osband and Ross, "Problems in the investigational study and clinical use of cancer immunotherapy", Immunology Today 11: 193-195 (1990).
Queen et al., "A Humanized Antibody that binds to the Interleukin 2 Receptor", Proc. Natl. Acad. Sci. USA 86: 10029-10033 (1989).
Reichmann et al., "Reshaping Human Antibodies for Therapy", Nature 332: 323-327 (1988).
Schumacher et al., "Use of Mouse Anti-Rabies Monoclonal Antibodies in Postexposure Treatment of Rabies", J. Clin Invest. 84: 971-975 (1989).
Winter and Milstein, "Man-made Antibodies", Nature 349: 293-299 (1991).
Wu and Kabat, "An Analysis of the Sequences of the Variable Regions of Bence Jones Proteins and Myeloma Light Chains and Their Implications for Antibody complementarity", J. Exp. Med 137: 211-250 (1970).
Dietzschold Bernhard
Koprowski Hilary
Rupprecht Charles
Eisenschenk Frank C.
Thomas Jefferson University
LandOfFree
Methods for treating post-exposure rabies and anti-rabies compos does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating post-exposure rabies and anti-rabies compos, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating post-exposure rabies and anti-rabies compos will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1605512